by rotation consisting of Mr. Suthikiati Chirathivat Mr. Ek-Rit Boonpiti Mr. Russell L. Kekuewa and Mr. Worachai Bhicharnchitr as directors and independent directors of the Company for another term
water, wastewater treatment and hydrogen and supplies its utilities to the Artlant PTA plant. PTA is a core strategic business of IVL and we are confident that over time the Portugal PTA plant will
subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st
suppliers. The plant now has been completed but still in the process of mechanical testing and improving the treatment formula. For the RDF facility in the second quarter, the Company has started to adjust
Q2/2019 ∆% Q1/2020 ∆% Revenues from sales of medical equipment and services 431,618 440,596 -2% 301,848 43% Revenues from sales and beauty treatment services 3,568 43,985 -92% 22,202 -84% Interest
perform duties or provide services honestly and a wrongful treatment of investor assets in contravention of the governing Notification of the Capital Market Supervisory Board. The SEC therefore revoked his
Civil Court (Undecided Case No. 2374/2562 and Decided Case No. 6984/2563). The Court of Appeal’s decision is final.SEC Secretary-General Ruenvadee Suwanmongkol said: “This is a case of unfair treatment
Development (OECD), which cover six areas as follows: 1. Enforcement and CG framework 2. Rights of shareholders 3. Equitable treatment of shareholders 4. Roles of stakeholders in CG 5. Disclosure and
Development (OECD), which cover six areas as follows: 1. Enforcement and CG framework 2. Rights of shareholders 3. Equitable treatment of shareholders 4. Roles of stakeholders in CG 5. Disclosure and
treatment income of chronic diseases from Social Security Office. Subsequently, Mr. Kumpol Plussind commit offense in using Mr. Krit Plussind's and Miss Kullapa Plussind's securities trading